Staff DevOps Engineer, Valo Health
Platform for drug development and discovery
Open for applications
Platform for drug development and discovery
101-200 employees
Open for applications
101-200 employees
Company mission
To make the drug discovery and development process faster, less expensive, and with a higher probability of success.
Role
Who you are
- Proficient in Python, and shell scripting
- Proficient in administering AWS environments: Linux EC2 instances, EKS clusters, and general networking and security best practices
- Comfortable with Software Engineering best practices such as the use of source control systems (specifically Git), code review, automated testing, and CI/CD pipelines
- Experience with GitLab, including the deployment and administration of a self-managed GitLab server (with GitLab CI)
- Familiar with automation of cloud deployment and blueprints (e.g. Terraform, Pulumi)
What the job involves
- We are looking for DevOps engineers to help manage the AWS Cloud infrastructure for our Data Science and Machine Learning environments. A successful candidate should be equally adept in handling day-to-day problems encountered by our users, as well as able to see the larger picture and change our infrastructure to lower our overall operational costs and improve user experience
- Handle a ticket duty to resolve user problems in an AWS Cloud Environment
- Create tools and processes to incrementally allow self-service by users to decrease the overall support burden and empower users
- Able to extract the general shapes of problems based on ad hoc tasks and find a technical path to automate away repetitive tasks and/or create tools and processes to allow self-service by users to decrease user burden
Our take
Drug development is a critical component of health care. Reducing costs, improving discovery processes, and accelerating drug development are all critical to success in the drug pipeline. Using human-centric data and ML-anchored computation, Valo Health’s integrated drug development platform, known as Opal, improves outcomes in drug development, by leveraging advanced data analysis.
Drug development entails a variety of steps including molecule discovery, clinical development, and target discovery. With the vast amount of data that is generated, a system like Opal incentivizes investment in outcomes that are more likely to correspond with effective treatments. This reduces the number and expense of clinical trials needed to demonstrate drug effectiveness.
There are a variety of competitors in the data-driven drug discovery field, including insitro, Atomwise, and Exscietia, but this vast market should still offer enough space for Valo Health to grow. In 2021, the company experienced a set-back in the surprise calling off of a merger that would have seen it go public, but despite this has continued to operate well and advance towards its goal of transforming the drug development process.
Freddie
Company Specialist at Welcome to the Jungle
Insights
Company
Funding (last 2 of 7 rounds)
Nov 2021
$1m
LATE VC
Jul 2021
$33.5m
LATE VC
Total funding: $487.5m
Company benefits
- Medical, Dental, and Vision Insurance
- Flexible Time-off
- 401K
- Corporate Engagement Opportunities with Local Non-Profit Organizations
- Commuter Reimbursement
- Fitness Reimbursement
- Pet Insurance
Company values
- Put Patients First
- Succeed As A Team
- There Is No Failure
- Think The Best Of One Another
- Time Is Our Only Limitation
- Take Collective Ownership
Company HQ
Back Bay East, Boston, MA
Articles
Leadership
Brian Alexander
(CEO)Also a Partner at Flagship Pioneering. Previously SVP of Genentech, CEO of Foundation Medicine and was a n Associate Professor at Harvard Medical School.
Brett Blackman
(COO)Member of the Board of Directors at Stanley Manne Children's Research Institute. Previously Interim Chief Scientific Officer at Omega Therapeutics and was a Strategic R&D Advisor at Ohana Biosciences, Inc.
Share this job
View 4 more jobs at Valo Health